Literature DB >> 22778211

Henoch-Schönlein purpura: a clinical case with dramatic presentation.

João Bento1, Adriana Magalhães, Conceição Souto Moura, Venceslau Hespanhol.   

Abstract

A case study involving a 55-year-old Caucasian male with end-stage glomerulosclerosis is presented here. Kidney biopsies showed no deposits on imunofluorescent microscopy. Relapsing massive haemoptysis and suspected bronchovascular malformation required lung lobectomy which revealed malformative and tortuous small blood vessels, with no vasculitis. Blood antinuclear antibodies, antineutrophil cytoplasmic antibodies and antiglomerular basement membrane antibodies were undetectable. Seric immunoglobulins and complement levels were normal. Three months later, arthralgia and joint oedema first appeared. Skin biopsy revealed vasculitis immune-reactive to immunoglobulin A. Systemic corticotherapy was then started. Two weeks later, the patient presented with abdominal pain melena and rectal bleeding (haematoquesia). Endoscopic study showed diffuse gastrointestinal haemorrhage. Angiographic study revealed diffuse lesions compatible with vasculitis and haemorrhage from multiple spots. Cyclophosphamide and then intravenous immunoglobulin were associated to treatment without response. Increasing blood loss occurred, with massive gastrointestinal haemorrhage and haemorrhagic ascitis. Death occurred due to uncontrolled diffuse bleeding. Necropsy findings showed generalised small vessels vasculitis compatible with Henoch-Schönlein purpura.

Entities:  

Mesh:

Year:  2010        PMID: 22778211      PMCID: PMC3029645          DOI: 10.1136/bcr.12.2009.2555

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  F T Saulsbury
Journal:  Curr Opin Rheumatol       Date:  2001-01       Impact factor: 5.006

Review 2.  Small-vessel vasculitis.

Authors:  J C Jennette; R J Falk
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

3.  Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins.

Authors:  A Kusuda; K Migita; M Tsuboi; M Degawa; N Matsuoka; M Tominaga; A Kawakami; Y Kawabe; T Taguchi; K Eguchi
Journal:  Intern Med       Date:  1999-04       Impact factor: 1.271

Review 4.  Respiratory system involvement in systemic vasculitides.

Authors:  P Manganelli; P Fietta; M Carotti; A Pesci; F Salaffi
Journal:  Clin Exp Rheumatol       Date:  2006 Mar-Apr       Impact factor: 4.473

5.  Henoch-Schönlein Purpura in adults: outcome and prognostic factors.

Authors:  Evangéline Pillebout; Eric Thervet; Gary Hill; Corinne Alberti; Philippe Vanhille; Dominique Nochy
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

6.  Massive gastrointestinal haemorrhage in isolated intestinal Henoch-Schonlein purpura with response to intravenous immunoglobulin infusion.

Authors:  Andrew A O Fagbemi; Franco Torrente; Andrew J W Hilson; Michael A Thomson; Robert B Heuschkel; Simon H Murch
Journal:  Eur J Pediatr       Date:  2006-11-21       Impact factor: 3.183

7.  Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients.

Authors:  W-L Chang; Y-H Yang; Y-T Lin; B-L Chiang
Journal:  Acta Paediatr       Date:  2004-11       Impact factor: 2.299

8.  Pulmonary involvement in Henoch-Schönlein purpura.

Authors:  Hassan F Nadrous; Aimee C Yu; Ulrich Specks; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2004-09       Impact factor: 7.616

9.  Henoch-Schönlein purpura in children and adults: clinical differences in a defined population.

Authors:  Carlos García-Porrúa; Maria C Calviño; Javier Llorca; José M Couselo; Miguel A González-Gay
Journal:  Semin Arthritis Rheum       Date:  2002-12       Impact factor: 5.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.